{"id":193388,"date":"2026-06-29T00:00:00","date_gmt":"2026-06-29T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041069-medtech-cardiac-rhythm-management-devices-market\/"},"modified":"2026-07-21T11:07:20","modified_gmt":"2026-07-21T11:07:20","slug":"48000642-medtech-cardiac-rhythm-management-devices-market-insights-europe","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/48000642-medtech-cardiac-rhythm-management-devices-market-insights-europe\/","title":{"rendered":"Cardiac Rhythm Management Devices &#8211; Market Insights &#8211; Europe"},"content":{"rendered":"<p>The European <abbr title=\"Cardiac Rhythm Management\">CRM<\/abbr> device market will continue to grow modestly over the forecast period because of rising <abbr title=\"Insertable Cardiac Monitor\">ICM<\/abbr> procedure volumes, the introduction of dual-chamber leadless pacemakers, and increased adoption of premium-priced devices such as <abbr title=\"Cardiac Resynchronization Therapy\">CRT<\/abbr> devices, single-chamber leadless pacemakers, and extravascular <abbr title=\"Implantable Cardioverter Defibrillator\">ICD<\/abbr>s. However, revenue growth will be limited by <abbr title=\"Average Selling Price\">ASP<\/abbr> declines driven by increasing competition in the leadless pacemaker and extravascular <abbr title=\"Implantable Cardioverter Defibrillator\">ICD<\/abbr> markets.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the European <abbr data-abbreviation-entity=\"9036\" title=\"Cardiac Rhythm Management\">CRM<\/abbr> device market from 2019 through 2035.<\/p>\n<p><strong>The highly saturated <abbr title=\"Cardiac Rhythm Management\">CRM<\/abbr> device market will drive competitors to focus on innovation as a key strategy for growth.<\/strong><\/p>\n<p>Which segments are saturated, and which segments continue to see dynamic growth?<\/p>\n<p>How do epidemiological trends and new technology influence growth in different pulse generator product segments?<\/p>\n<p>How can individual competitors realize growth in this large but fairly mature market?<\/p>\n<p>Will mergers and acquisitions play a key role in this device market?<\/p>\n<p><strong>The emergence of <abbr data-abbreviation-entity=\"10968\" title=\"Conduction System Pacing\">CSP<\/abbr> is reshaping clinical practice and device adoption trends in the <abbr data-abbreviation-entity=\"9036\" title=\"Cardiac Rhythm Management\">CRM<\/abbr> device market.<\/strong><\/p>\n<p>Which <abbr data-abbreviation-entity=\"9036\" title=\"Cardiac Rhythm Management\">CRM<\/abbr> device segments are most affected by <abbr data-abbreviation-entity=\"10968\" title=\"Conduction System Pacing\">CSP<\/abbr> adoption?<\/p>\n<p>To what extent are the clinical benefits of <abbr data-abbreviation-entity=\"10968\" title=\"Conduction System Pacing\">CSP<\/abbr> compared with traditional pacing approaches driving shifts in procedure mix?<\/p>\n<p>How is growing interest in <abbr data-abbreviation-entity=\"10968\" title=\"Conduction System Pacing\">CSP<\/abbr> expected to influence longerterm market dynamics for established pacing technologies?<\/p>\n<p><b>Adoption of novel devices will offset waning revenue for traditional devices in the European <abbr title=\"Cardiac Rhythm Management\">CRM<\/abbr> market.<\/b><\/p>\n<p>What is the predicted uptake of novel devices such as leadless pacemakers and extravascular <abbr title=\"Implantable Cardioverter Defibrillator\">ICD<\/abbr>s? Will leadless pacemakers and extravascular <abbr title=\"Implantable Cardioverter Defibrillator\">ICD<\/abbr>s become the standard of care?<\/p>\n<p>To what extent will the uptake of leadless pacemakers and extravascular <abbr title=\"Implantable Cardioverter Defibrillator\">ICD<\/abbr>s offset declining revenue in other markets?<\/p>\n<p>How will the availability and increasing clinical adoption of dual-chamber leadless pacemakers impact the traditional dual-chamber pacemaker market?<\/p>\n<p><strong>How are evolving clinical evidence and innovation-driven competition shaping the European <abbr title=\"Cardiac Rhythm Management\">CRM<\/abbr> device market?<\/strong><\/p>\n<p>How will robust clinical data generation influence physician adoption, reimbursement decisions, and uptake of disruptive <abbr title=\"Cardiac Rhythm Management\">CRM<\/abbr> devices?<\/p>\n<p>How will ongoing clinical trials impact competitive positioning and segment-level market share dynamics?<\/p>\n<p>How will the adoption of novel devices, including leadless pacemakers and extravascular <abbr title=\"Implantable Cardioverter Defibrillator\">ICD<\/abbr>s, reshape the competitive landscape and future growth strategies?<\/p>\n","protected":false},"template":"","class_list":["post-193388","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiac-rhythm-management-devices","medtech-therapy-area-cardiovascular","medtech-geography-europe","medtech-date-2828"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/193388","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=193388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}